Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,762 | 35,455 | 41,648 | 2,639 | 14,560 |
| Receivables | 983 | 551 | 650 | N/A | N/A |
| TOTAL | $57,119 | $36,586 | $43,159 | $3,022 | $14,849 |
| Non-Current Assets | |||||
| PPE Net | 335 | 408 | 410 | 468 | 536 |
| Other Non-Current Assets | 0 | 78 | 0 | 0 | 1,489 |
| TOTAL | $335 | $486 | $410 | $468 | $2,025 |
| Total Assets | $57,454 | $37,072 | $43,569 | $3,490 | $16,874 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,021 | 5,281 | 2,558 | 2,232 | 3,293 |
| Accrued Expenses | 3,166 | 2,971 | 3,848 | 2,519 | 1,981 |
| Other current liabilities | N/A | 0 | 0 | 1,000 | N/A |
| TOTAL | $12,144 | $8,838 | $6,992 | $5,751 | $8,051 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,375 |
| Deferred Revenues | 1,957 | 586 | 586 | N/A | N/A |
| TOTAL | $N/A | $1,319 | $1,465 | $N/A | $4,375 |
| Total Liabilities | $12,144 | $10,157 | $8,457 | $5,751 | $12,426 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,984 | 4,963 | 4,477 | 3,636 | 2,867 |
| Common Shares | 40 | 36 | 36 | 23 | 23 |
| Retained earnings | -344,692 | -333,366 | -324,471 | -316,811 | -309,365 |
| TOTAL | $45,310 | $26,915 | $35,112 | $-2,261 | $4,448 |
| Total Liabilities And Equity | $57,454 | $37,072 | $43,569 | $3,490 | $16,874 |